Market Structure & Competition - A fragmented system shaped by brokers, lenders, and uneven control

A fragmented system shaped by brokers, lenders, and uneven control

This is a market built in layers — not as a system

The UK dental patient finance market did not evolve as an integrated system.

It developed in layers:

• brokers built distribution

• lenders provided capital

• practices executed the journey

At no point did a single player control:

• the full patient journey

• underwriting inputs

• pricing consistency

• operational workflows

Result

The market functions — but without alignment between risk, control, and execution.

1. The broker-led foundation

For most of its history, the market was dominated by:

• Medenta

• Chrysalis Finance

• Dental Finance / Financing First

How the model worked

• brokers:

  • owned relationships with practices

  • distributed finance

• lenders:

  • funded loans

  • carried credit and Section 75 risk

Key lender relationships (historically)

• Hitachi (now Novuna)

• Close Brothers Retail Finance (Braemer brand in dentistry)

• Shawbrook (earlier phase)

Structural characteristic

The entity originating the loan did not control capital or underwriting.

2. Medenta: persistent distribution, constrained funding

• founded ~2006

• acquired by Wesleyan / Practice Plan (c. 2011–2012)

Evolution

• initially brokered via lenders (primarily Hitachi)

• briefly operated with internal bank funding

• lost this when Wesleyan exited banking

Current structure

• operates primarily via V12 (Secure Trust Bank)

• tripartite relationship: practice ↔ Medenta ↔ V12

Important clarifications

• Medenta did not operate the AR model (this was Chrysalis)

• relies on lender infrastructure for:

  • underwriting

  • capital

  • core systems

Additional context

• longstanding relationship with Hitachi ended

• legal dispute historically impacted positioning

• currently limited lender optionality

Structural observation

Medenta controls distribution—but not capital, underwriting, or system design.

3. Chrysalis: consolidation and shift toward balance sheet lending

• emerged alongside early Medenta expansion

• scaled across:

  • dentistry

  • hospitals

Key structural moment

• Dental Finance / Financing First merged into Chrysalis (c. 2021–2022)

  • driven by loss of funding partners

Funding evolution

• historically:

  • worked with multiple external lenders (incl. Hitachi and Omni Retail Finance)

• relationships repeatedly broke down:

  • particularly around risk exposure

Current direction

• moving toward:

  • internal lending structures

  • balance sheet control (e.g. Citi-backed vehicles)

Structural observation

Chrysalis has shifted from broker to lender—but without fully rebuilding the system layer.

4. Close Brothers: exit following loss exposure

• operated via Close Brothers Retail Finance

• dentistry accessed through:

  • Braemer brand

Key events

• Scandal related to Purplebricks feature on Dave (TV) 

• exposure to Finest Dental collapse (~2020)

Outcome

• incurred material losses

• subsequently:

  • sold its retail finance loan book

  • exited the sector

Structural observation

Loss events directly triggered exit from dentistry.

5. Novuna (Hitachi): scale with selective participation

• large-scale retail finance lender

• part of Hitachi group

Characteristics

• very low cost of capital

• strong position in large enterprise relationships

Key events

• exposure to:

  • Dentix collapse

• significant losses influenced:

  • withdrawal from smaller dental practices

Current positioning

• focused on:

  • large corporate groups (e.g. Bupa)

• reduced presence in:

  • independent practices and small groups

Structural observation

Participation is driven by scale and risk concentration—not market coverage.

6. V12 (Secure Trust Bank): stable capital, multi-sector focus

• deposit-funded lender

• significant scale in retail finance

Role in dentistry

• primary funding partner for: 

  • Medenta

• Narrowed focus as other lenders withdrew

Observations

• has not experienced the same level of visible losses in dentistry

• maintains key relationships (e.g. mydentist, Medenta)

Structural characteristic

• dentistry is:

  • one vertical among many

• primary focus remains:

  • large-scale retail partnerships

Structural observation

V12 participates in dentistry—but is not dependent on it.

7. Failed and withdrawn entrants

Multiple entrants have attempted to enter dentistry and failed to scale:

Examples

• Klarna → entered, then exited (fragmentation, low standardisation)

• Affirm → explored, did not scale

• humm (Australia) → limited traction

• HSBC (Divido) → failed entry

• Barclays → incomplete integration

• BNP Paribas (Laser) → exited

• Lloyds Bank → exited retail finance

Common challenges

• fragmented provider base

• variability across practices

• lack of standardised workflows

• difficulty underwriting consistently

Observation

Dentistry has consistently resisted generalist retail finance models.

8. Pricing: opaque and negotiation-driven

Historically, pricing has been:

• non-transparent

• inconsistent

• negotiated individually

Observed behaviour

• identical practices paying different rates

• large groups not necessarily receiving best pricing

• perception of value tied to negotiation outcome

Tabeo’s intervention (2018)

• introduced:

  • public pricing

• created:

  • a market benchmark

Market response

• transparency adopted unevenly

• pricing still largely negotiated

Structural observation

Until Tabeo, pricing has been determined by negotiation—not system logic.

9. Internal economics: opacity within groups

Within larger dental groups:

• central teams negotiate supplier terms

• associates share revenue

Observed practice

• discounts not always passed through fully

• pricing visibility managed internally

Structural observation

Opacity is maintained both externally and internally.

10. Technology: adapted, not purpose-built

Most systems in the market:

• originate from:

  • general lending infrastructure

Characteristics

• long application flows

• desktop-first design

• reliance on staff

Observed comparison

• legacy:

  • ~50–70 interactions

• newer systems:

  • ~20–25 interactions

Practical implication

• patient often completes application:

  • with staff support

  • over extended time

11. Operational model: process-heavy and delayed

Finance operates operationally as:

• a workflow

• not an instant payment

Key components

Application

• staff-assisted in many cases

Payout

• requires: manual confirmation (legacy providers)

Observed delays

• 2–4 weeks payout cycles

• even in large organisations

Reconciliation

• separate from PMS

• manual matching required

Structural observation

Finance introduces operational overhead beyond the transaction.

12. Regulatory baseline (pre-2026)

Before July 2026:

• significant share of lending:

  • under 12 months

  • interest-free

Which meant

• not FCA regulated

• no Section 75 exposure

• no Financial Ombudsman escalation

Effect

• reduced compliance burden

• lower perceived risk

Final observation

The UK dental patient finance market has evolved through:

• broker-led distribution

• lender-funded capital

• practice-level execution

And is characterised by:

• fragmented control

• inconsistent pricing

• adapted (not purpose-built) technology

• operational complexity

It is a functioning market — but not an integrated one.